• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to letter to the editor "proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors".

作者信息

Cardoso Ana Beatriz Ribeiro, Zimmermann Amanda Cristina, Raverot Gerald, Nunes-Nogueira Vania Dos Santos

机构信息

Department of Internal Medicine, São Paulo State University (UNESP), Medical School, Botucatu, São Paulo, Brazil.

Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Bron, France.

出版信息

Pituitary. 2025 Jul 23;28(4):86. doi: 10.1007/s11102-025-01558-5.

DOI:10.1007/s11102-025-01558-5
PMID:40702283
Abstract
摘要

相似文献

1
Response to letter to the editor "proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors".对致编辑信“关于垂体癌和侵袭性垂体瘤靶向免疫治疗的提议考量”的回复
Pituitary. 2025 Jul 23;28(4):86. doi: 10.1007/s11102-025-01558-5.
2
Proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors.垂体癌和侵袭性垂体肿瘤靶向免疫治疗的拟议考量。
Pituitary. 2025 Jul 1;28(4):79. doi: 10.1007/s11102-025-01551-y.
3
Aggressive pituitary tumors and pituitary carcinomas: Definition, management, and overview for clinical practice.侵袭性垂体肿瘤和垂体癌：临床实践的定义、管理及概述
Neurooncol Adv. 2025 Jan 2;7(Suppl 1):i17-i28. doi: 10.1093/noajnl/vdae114. eCollection 2025 Jul.
4
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review.PI3K/AKT/mTOR 和 RAF/MEK/ERK 通路激活在侵袭性垂体腺瘤中的作用——新的潜在治疗方法——系统评价。
Int J Mol Sci. 2023 Jun 30;24(13):10952. doi: 10.3390/ijms241310952.
5
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.全基因组甲基化谱分析可区分良性、侵袭性和转移性垂体神经内分泌肿瘤。
Acta Neuropathol. 2024 Nov 23;148(1):68. doi: 10.1007/s00401-024-02836-5.
6
Driving Best Practices Throughout the Treatment Journey for Patients with NSCLC with Actionable Alterations: A Podcast Discussion.为具有可操作改变的非小细胞肺癌患者在整个治疗过程中推动最佳实践：播客讨论
Adv Ther. 2025 May 22. doi: 10.1007/s12325-025-03195-7.
7
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis.抗肿瘤药物疗法对癌和侵袭性垂体瘤的影响：一项系统评价和荟萃分析。
Pituitary. 2025 Jun 2;28(3):70. doi: 10.1007/s11102-025-01541-0.
8
Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review.替莫唑胺治疗耐药性泌乳素分泌型垂体腺瘤和癌：一项系统评价
Hormones (Athens). 2017 Apr;16(2):139-149. doi: 10.14310/horm.2002.1729.
9
Prolactin-secreting pituitary carcinomas with intra- and extracranial metastasis: case report and review.伴有颅内和颅外转移的泌乳素分泌型垂体癌：病例报告及文献复习
Zh Vopr Neirokhir Im N N Burdenko. 2025;89(1):83-93. doi: 10.17116/neiro20258901183.
10
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas.欧洲内分泌学会关于侵袭性垂体肿瘤和垂体癌管理的临床实践指南修订版。
Eur J Endocrinol. 2025 May 30;192(6):R45-R78. doi: 10.1093/ejendo/lvaf100.

本文引用的文献

1
Proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors.垂体癌和侵袭性垂体肿瘤靶向免疫治疗的拟议考量。
Pituitary. 2025 Jul 1;28(4):79. doi: 10.1007/s11102-025-01551-y.
2
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas.欧洲内分泌学会关于侵袭性垂体肿瘤和垂体癌管理的临床实践指南修订版。
Eur J Endocrinol. 2025 May 30;192(6):R45-R78. doi: 10.1093/ejendo/lvaf100.
3
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis.
抗肿瘤药物疗法对癌和侵袭性垂体瘤的影响：一项系统评价和荟萃分析。
Pituitary. 2025 Jun 2;28(3):70. doi: 10.1007/s11102-025-01541-0.
4
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study.真实世界中免疫治疗对垂体瘤的疗效和预测因素：一项队列研究。
Eur J Endocrinol. 2022 Oct 17;187(5):685-696. doi: 10.1530/EJE-22-0647. Print 2022 Nov 1.